Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 86-90, 2020.
Article in Chinese | WPRIM | ID: wpr-817383

ABSTRACT

ABSTRACT OBJECTIVE:To establish a method for content determination of paclitaxel in malignant ascites of tumor patients. METHODS:LC-MS/MS method was adopted. Using vindoline as internal standard,the content of paclitaxel in ascites of tumor patients was determined. The separation was performed on Zorbax SB-C18 column with mobile phase consisted of aqueous solution (containing 0.1% formic acid and 10 mmol/L ammonium acetate)-acetonitrile(40 ∶ 60,V/V)at the flow rate of 0.25 mL/min. the column temperature was 30 ℃,and sample size was 5 μL. The ion source was electrospray ion source,and the detection mode was multiple ion monitoring positive ion mode. MS parameters were set as following as dry gas temperature 350 ℃,dry gas flow rate 10 L/min,capillary voltage 4 000 V. Quantitative determination was operated in the multiple reaction monitoring(MRM)mode, with the ion transitions m/z 876.5→308.0 for paclitaxel and m/z 457.3→188.1 for the internal standard. The fragment voltage/ collision energy for paclitaxel and the internal standard were 250 V/30 eV,and 150 V/20 eV,respectively. RESULTS:The linear range of paclitaxel were 25-2 500 ng/mL(r2=0.996 5,n=7). The lowest limit of quantitation was 25 ng/mL. RSDs of inter-day and intra-day precision tests were 0.61% -3.62%(n=5,3). Accuracies were 95.34% -98.76%(n=5,3). RSDs of extraction recovery were 3.19%-3.72%(n=3). CV of matrix effect were 1.52%-2.93%(n=3). RE of stability tests were lower than 3%(n= 3). CONCLUSIONS:The method is simple,accurate and suitable for the content determination of paclitaxel in malignant ascites of tumor patients.

SELECTION OF CITATIONS
SEARCH DETAIL